About adsilico
adsilico is a Healthcare company based in London (United Kingdom) founded in 2022 by Alejandro Frangi, Zeike Taylor, Nishant Ravikumar, and Sheena Macpherson. It operates as an in-silico trial solutions for medical device testing are developed. adsilico has raised $4.56 million across 1 funding round from investors including University of Leeds, Northern Gritstone and Mainspring Fund Services. Its chief executive is Sheena Macpherson. adsilico offers products and services including In Silico Trials and Virtual Populations. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is ADSILICO LIMITED. Its competitors include Unlearn, ELEM Biotech, Virtonomy, Akkure and Demiurge Technologies and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
Adsilico was founded in 2022 in London, United Kingdom, within the medical technology sector. Computational modeling and simulations are utilized by the company to evaluate device safety and performance in virtual patients. Operations focus on in-silico trials that support medical testing processes, with services centered on virtual assessments to inform regulatory and development decisions.
- Headquarters London, United Kingdom
- Founders Alejandro Frangi, Zeike Taylor, Nishant Ravikumar, Sheena Macpherson
- SectorsHealthcare
- Email••••••••
- Website adsilico.uk
- Social LinkedIn
- Legal Name Adsilico Limited
- Date of Incorporation 29 Jul, 2022
- Jurisdiction LEEDS, WEST YORKSHIRE, UNITED KINGDOM
- Total Equity Funding$4.56M (USD)
in 1 rounds
- Latest Funding Round$4.56M (USD), Seed
Feb 2024
- InvestorsUniversity of Leeds
& 3 more
Products & Services of adsilico
adsilico offers a comprehensive portfolio of products and services, including In Silico Trials and Virtual Populations.
Platform for assessing medical device safety using virtual patients.
Generates custom virtual models for diverse patient simulations in research.
Funding Insights of adsilico
adsilico has successfully raised a total of $4.56M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.56 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.56M
- Total Rounds 1
- Last Round Seed — $4.56M
- First Round $4.56M
(Feb 2024)
- Investors Count 4
All 1 funding rounds of adsilico with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $4.56M | Seed | – | Northern Gritstone, Parkwalk |
4 investors in total: 4 institutional.
Investors in adsilico
adsilico has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Leeds, Northern Gritstone and Mainspring Fund Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment firm focused on investing in science and technology firms | 2020 | northern-gritstone.com | Manchester, United Kingdom | |
Tech companies are invested in by Parkwalk venture capital firm. | – | parkwalkadvisors.com | London, United Kingdom | |
Provider of fund administration services | 2010 | mainspringfs.com | London, United Kingdom | |
Multiple courses and degrees across diversified streams are offered. | 1904 | leeds.ac.uk | Leeds, United Kingdom |
Investor details for adsilico
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of adsilico
6 people are tracked at adsilico (6 in leadership).
| Name | Role | Group |
|---|---|---|
Alejandro Frangi | Co-Founder | Leadership |
Zeike Taylor | Co-Founder | Leadership |
Nishant Ravikumar | Co-Founder | Leadership |
Sheena Macpherson | Co-Founder & CEO | Leadership |
Anthony Holmes | Chief Product Officer | Leadership |
Beckie Bown | Chief Financial Officer | Leadership |
Complete people profiles for adsilico
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of adsilico
2 dated milestones of adsilico across 2 years, from founding to its latest funding, stage changes and deals.
- Founded adsilico is founded.
- Funding First funding round of $4.6M.
Competitors of adsilico
adsilico has 8 listed competitors in our database, 6 of them funded. They include Unlearn, ELEM Biotech, Virtonomy, Akkure and Demiurge Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unlearn.ai | 2017 | San Francisco, United States | $127.13M | – | Provider of AI-based clinical trial management software | |
| elem.bio | 2018 | Barcelona, Spain | $2.27M | – | A simulation-based platform for virtual medical trials is provided. | |
| virtonomy.io | 2019 | Munich, Germany | $3.82M | – | Virtual patient simulations are provided for medical device development. | |
| akkure.com | 2016 | Dublin, Ireland | $3.37M | – | Blockchain-based platform for genomic data analytics is provided. | |
| demiurge.technology | 2015 | Zug, Switzerland | $9.5M | – | Developer of neural network models and neuromorphic chips | |
| electrictwin.com | 2020 | London, United Kingdom | $13.02M | – | AI-powered digital twin technology for research and clinical applications in the life sciences industry | |
| exoralabs.com | 2019 | Bengaluru, India | – | – | AI platform for healthcare summaries, data management, and insights optimization. | |
| hakobio.com | 2014 | Brussels, Belgium | – | – | Digital twin creation for biopharma facilities, simulation, training, and asset management. |
Detailed competitors of adsilico
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as adsilico (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Adsilico
Complete news archive for adsilico
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about adsilico
adsilico was founded in 2022 and raised its 1st funding round 2 years after it was founded.
adsilico is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Sheena Macpherson is the current CEO of adsilico. They have also founded this company.
adsilico is a funded company, having raised a total of $4.56M across 1 funding round to date. The company's 1st funding round was a Seed of $4.56M, raised on Feb 2024.
Adsilico was founded in 2022 in London, United Kingdom, within the medical technology sector. Computational modeling and simulations are utilized by the company to evaluate device safety and performance in virtual patients. Operations focus on in-silico trials that support medical testing processes, with services centered on virtual assessments to inform regulatory and development decisions.
adsilico's top competitors include Unlearn, Virtonomy and ELEM Biotech.
adsilico offers In Silico Trials and Virtual Populations.
adsilico has 4 investors. Key investors include University of Leeds, Northern Gritstone, Mainspring Fund Services, and Parkwalk.
adsilico operates through Adsilico Limited.